Filing Details
- Accession Number:
- 0001864317-22-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-14 17:07:31
- Reporting Period:
- 2022-09-14
- Accepted Time:
- 2022-09-14 17:07:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1677077 | Alzamend Neuro Inc. | ALZN | Pharmaceutical Preparations (2834) | 811822909 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864317 | J David Katzoff | 940 South Coast Drive Suite 200 Costa Mesa CA 92626 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-14 | 10,000 | $1.11 | 28,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
